欧洲细胞治疗市场预测至 2027 年 - COVID-19 影响和按治疗类型（同种异体、自体）进行的区域分析；产品（消耗品、设备、系统和软件）；技术（病毒载体技术、基因组编辑技术、体细胞技术、细胞永生化技术、细胞可塑性技术、三维技术）；应用（肿瘤学、心血管、骨科、伤口处理、其他应用）；最终用户（研究机构、医院、其他）和国家。
No. of Pages: 165 | Report Code: TIPRE00019052 | Category: Life Sciences
No. of Pages: 165 | Report Code: TIPRE00019052 | Category: Life Sciences
细胞疗法是将活的完整细胞注射、植入或移植到患者体内的过程。这项技术依赖于用健康的功能细胞替代功能失调的细胞。主要用于此类先进疗法的细胞是干细胞，因为它们能够分化成修复受损或有缺陷的组织或细胞所需的特定细胞。此外，细胞疗法在再生医学的开发中也有应用。慢性病患病率的不断上升、再生药物的采用不断增加以及细胞疗法的批准数量不断增加可能会推动预测期内细胞疗法市场的增长。
欧洲细胞治疗市场预计将从2019年的21.257亿美元增至2027年的36.107亿美元；预计 2019 年至 2027 年复合年增长率为 6.9%。慢性病患病率的增加、再生药物的不断采用以及细胞疗法的批准数量不断增加等因素预计将在未来几年推动细胞治疗市场的增长。然而，在预测期内，市场可能会受到新兴国家细胞疗法制造成本高等风险因素的影响。
COVID-19 大流行已成为整个欧洲地区最重大的挑战。由于大多数欧洲国家宣布封锁导致供应链中断和需求中断等因素，细胞治疗仪器市场在COVID-19危机之初出现了一些短缺。然而，由于政府的支持，对细胞疗法的需求急剧增加。
市场范围欧洲细胞治疗市场包括治疗类型、产品、技术、应用、最终用户和国家。就治疗类型而言，2019年，由于有大量获批产品可供临床使用，同种异体疗法所占份额最高。然而，在预测期内，自体移植市场也可能实现最高的复合年增长率。
与欧洲细胞治疗市场报告相关的几个主要一手和二手来源是世界卫生组织 (WHO)、欧洲疾病预防和控制中心 (ECDC) ）、再生医学联盟、美国国立卫生研究院、安东尼·诺兰基金会等。
Strategic insights for Europe Cell Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 2,125.7 Million |
| Market Size by 2027 | US$ 3,610.7 Million |
| Global CAGR (2019 - 2027) | 6.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 治疗类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Cell Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Cell Therapy Market is valued at US$ 2,125.7 Million in 2019, it is projected to reach US$ 3,610.7 Million by 2027.
As per our report Europe Cell Therapy Market, the market size is valued at US$ 2,125.7 Million in 2019, projecting it to reach US$ 3,610.7 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.
The Europe Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cell Therapy Market report:
The Europe Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Cell Therapy Market
